Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
Clinical trial NCT00519259 · UNKNOWN
Trial details
- NCT number
- NCT00519259
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.